Siemens IMMULITEIMMULITE 1000 BR-MA

Nazione: Singapore

Lingua: inglese

Fonte: HSA (Health Sciences Authority)

Commercializzato da:

SIEMENS HEALTHCARE PTE. LTD.

Classe:

Class C IVD

Prodotto da:

Siemens Healthcare Diagnostics Products Limited

Area terapeutica:

Immunology

Indicazioni terapeutiche:

It is for in vitro diagnostic use with the IMMULITE®/IMMULITE® 1000 analyzers – for the quantitative measurement of CA 15-3 antigen in human serum, as an aid in the detection of recurrence in previously treated stage II and stage III breast cancer patients, and in the management of metastatic breast cancer patients by monitoring disease progression or response to treatment. Serial testing for patient CA 15-3 values should be used in conjunction with other clinical methods used for detecting early recurrence in stage II and stage III disease and for monitoring response to treatment in patients with metastatic breast cancer.

Dettagli prodotto:

Models: IMMULITE®/IMMULITE® 1000 BR-MA (100 tests) - LKBR1, BR-MA Test Units - LBR1, BR-MA Reagent Wedges - LBRA, BR-MA Reagent Wedges - LBRB, BR-MA Adjustors - LBRL, BR-MA Adjustors - LBRH, BR-MA Sample Diluent - LBRZ, BR-MA Bead Pack - L2BR12, BR-MA Reagent Wedges - L2BRA2, Multi-Diluent 2 - L2M2Z, Multi-Diluent 2 - L2M2Z4

Data dell'autorizzazione:

2013-09-20